Prague.bio Conference 2026 — Program
4th edition · One-day conference
Welcome to the 4th edition of the Prague.bio Conference.
Adam Vojtech
Minister of Health of the Czech Republic
Jan Konvalinka
Director · IOCB
Petra Kinzlova
CEO · Prague.bio
Can Europe close the biotech competitiveness gap? Claire Skentelbery discusses the ambitions behind the EU Biotech Act and the policy changes needed to help European biotech companies start, scale, and stay in Europe.
Claire Skentelbery
Director General · EuropaBio
Leading investors share their perspectives on the current funding environment, investment priorities, and what biotech founders need to demonstrate to attract capital in today's market.
From bench to biotech: Chris Bladen discusses the realities of turning academic research into a venture-backed biopharma company, sharing lessons from the scientific, regulatory, and commercial challenges that shape the path from discovery to impact.
Chris Bladen
Zymedyne Therapeutics
First batch of teams competing for the main prizes.
Insights into the EIF's role in strengthening Europe's innovation ecosystem, supporting venture capital, and improving access to financing for high-growth life science companies.
Miruna-Cristina Gala
European Investment Fund (EIF)
Second batch of teams competing for the main prizes.
Industry leaders discuss the shifting centres of gravity in global biotech, from policy and funding uncertainty in the United States to the rapid rise of China and Asia as innovation powerhouses, and what these developments mean for Europe's future role in the sector.
Discover next breakthrough technologies and mingle during the Poster Session.
Lessons from one of Europe's leading innovation ecosystems on translating scientific breakthroughs into successful ventures, building founder communities, and accelerating biotech commercialization.
Markus Gerhard
TUM Venture Labs
Beyond the hype: can TechBio deliver? Experts discuss where AI and computational biology are already creating value, which business models are proving sustainable, and what it takes to build globally competitive TechBio companies in Europe.
Winners of the Pitch Competition announced; and the programme of the conference is officially concluded.